125 related articles for article (PubMed ID: 38430581)
1. Long-term di-(2-ethylhexyl) phthalate exposure reduces sorafenib treatment efficacy by enhancing mesenchymal transition in hepatocellular carcinoma.
Shih MS; Suk FM; Chiu WC; Lee CY; Hsu FY; Liao YJ
Ecotoxicol Environ Saf; 2024 Mar; 273():116161. PubMed ID: 38430581
[TBL] [Abstract][Full Text] [Related]
2. Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma.
Suk FM; Liu CL; Hsu MH; Chuang YT; Wang JP; Liao YJ
Sci Rep; 2019 Nov; 9(1):17259. PubMed ID: 31754201
[TBL] [Abstract][Full Text] [Related]
3. Plasticizer Di-(2-Ethylhexyl)Phthalate Induces Epithelial-to-Mesenchymal Transition and Renal Fibrosis In Vitro and In Vivo.
Wu CT; Wang CC; Huang LC; Liu SH; Chiang CK
Toxicol Sci; 2018 Jul; 164(1):363-374. PubMed ID: 29669060
[TBL] [Abstract][Full Text] [Related]
4. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
[TBL] [Abstract][Full Text] [Related]
6. KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program.
Xu Y; Xu H; Li M; Wu H; Guo Y; Chen J; Shan J; Chen X; Shen J; Ma Q; Liu J; Wang M; Zhao W; Hong J; Qi Y; Yao C; Zhang Q; Yang Z; Qian C; Li J
Cancer Lett; 2019 Jul; 454():78-89. PubMed ID: 30980868
[TBL] [Abstract][Full Text] [Related]
7. Lifelong exposure to di-(2-ethylhexyl)-phthalate induces tumors in liver and testes of Sprague-Dawley rats.
Voss C; Zerban H; Bannasch P; Berger MR
Toxicology; 2005 Jan; 206(3):359-71. PubMed ID: 15588926
[TBL] [Abstract][Full Text] [Related]
8. Di(2-ethylhexyl) phthalate (DEHP) increases proliferation of epithelial breast cancer cells through progesterone receptor dysregulation.
Crobeddu B; Ferraris E; Kolasa E; Plante I
Environ Res; 2019 Jun; 173():165-173. PubMed ID: 30909102
[TBL] [Abstract][Full Text] [Related]
9. Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma.
Suk FM; Wang YH; Chiu WC; Liu CF; Wu CY; Chen TL; Liao YJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445279
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activity of sorafenib in a model of a pediatric hepatocellular carcinoma.
Nagel C; Armeanu-Ebinger S; Dewerth A; Warmann SW; Fuchs J
Exp Cell Res; 2015 Feb; 331(1):97-104. PubMed ID: 25447203
[TBL] [Abstract][Full Text] [Related]
11. SNGH16 regulates cell autophagy to promote Sorafenib Resistance through suppressing miR-23b-3p via sponging EGR1 in hepatocellular carcinoma.
Jing Z; Ye X; Ma X; Hu X; Yang W; Shi J; Chen G; Gong L
Cancer Med; 2020 Jun; 9(12):4324-4338. PubMed ID: 32324343
[TBL] [Abstract][Full Text] [Related]
12. Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects against Sorafenib Resistance in Hepatocellular Carcinoma.
Liao YJ; Hsu SM; Chien CY; Wang YH; Hsu MH; Suk FM
Molecules; 2020 Jun; 25(12):. PubMed ID: 32575795
[TBL] [Abstract][Full Text] [Related]
13. The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance.
Chow AK; Ng L; Lam CS; Wong SK; Wan TM; Cheng NS; Yau TC; Poon RT; Pang RW
PLoS One; 2013; 8(11):e78675. PubMed ID: 24244338
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Librosis.
Lee CY; Suk FM; Twu YC; Liao YJ
Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32471116
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1.
Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ
Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877
[TBL] [Abstract][Full Text] [Related]
16. Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes.
Butterworth BE; Bermudez E; Smith-Oliver T; Earle L; Cattley R; Martin J; Popp JA; Strom S; Jirtle R; Michalopoulos G
Carcinogenesis; 1984 Oct; 5(10):1329-35. PubMed ID: 6488454
[TBL] [Abstract][Full Text] [Related]
17. Subchronic Exposure to Di(2-ethylhexyl) Phthalate and Diisononyl Phthalate During Adulthood Has Immediate and Long-Term Reproductive Consequences in Female Mice.
Chiang C; Flaws JA
Toxicol Sci; 2019 Apr; 168(2):620-631. PubMed ID: 30649530
[TBL] [Abstract][Full Text] [Related]
18. Chronic di(2-ethylhexyl) phthalate exposure at environmental-relevant doses induces osteoporosis by disturbing the differentiation of bone marrow mesenchymal stem cells.
Zhang Y; Zheng L; Cheng D; Lei C; Li H; Zhou J; Zhang C; Song F; Zeng T; Zhao X
Sci Total Environ; 2024 Mar; 914():169918. PubMed ID: 38190899
[TBL] [Abstract][Full Text] [Related]
19. Maternal exposure to di-2-ethylhexyl phthalate (DEHP) depresses lactation capacity in mice.
Hou P; Dai W; Jin Y; Zhao F; Liu J; Liu H
Sci Total Environ; 2022 Sep; 837():155813. PubMed ID: 35550907
[TBL] [Abstract][Full Text] [Related]
20. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
Dong J; Zhai B; Sun W; Hu F; Cheng H; Xu J
PLoS One; 2017; 12(9):e0185088. PubMed ID: 28934275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
